Search result

World first COVID-19 vaccine booster study launches in NHS Greater Glasgow and Clyde

Volunteers from NHS Greater Glasgow and Clyde will soon be able to receive a third ‘booster’ COVID-19 vaccine through a new clinical trial launching this week The Cov-Boost study, backed by £19.3 million of government funding through the Vaccines Taskforce, will be run at Glasgow Clinical Research Facilities – one of 16 sites across the UK. It will be the first in the world to provid...

View Page

Vacancy: NRS Renal Clinical Lead

The Chief Scientist Office is looking to appoint a clinical lead for NRS Renal Hours: 0.1FTE/ 1 PA per week Length: 3 years initially, with the possibility to extend Salary: Pro-rata within the post holder’s pay s...

View Page

Vacancy: NRS Musculoskeletal Clinical Lead

The Chief Scientist Office is looking to appoint a clinical lead for NRS Musculoskeletal Hours: 0.2FTE/ 2 PAs per week Length: 3 years initially, with the possibility to extend Salary: Pro-rata within t...

View Page

First COVID-19 vaccine study for pregnant women launches in the UK

The first COVID-19 vaccine study in the UK recruiting pregnant women has been launched and will be open in NHS Lothian The phase 2/3 study aims to further understand the safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in healthy pregnant women, with approximately 235 volunteers involved throughout the UK. Following

View Page

Volunteers needed across NHS Greater Glasgow and Clyde and NHS Lothian for latest COVID-19 vaccine study

The latest vaccine study to open in the UK examining a new COVID-19 vaccine candidate is recruiting volunteers across Greater Glasgow and Clyde and Lothian Developed by the specialty vaccine company Valneva, the vaccine is being manufactured at the company’s site in Livingston, West Lothian, and is the only inactivated, adjuvanted (an ingredient to create a stronger immune response) COVID-19 vaccine in clinical development in Europe. Inactivated vaccines are a well-established...

View Page

Latest COVID-19 vaccine study launches in NHS Grampian

The latest COVID-19 vaccine study in the UK has opened in Scotland in NHS Grampian Medicago, a biopharmaceutical company based in Canada, and GlaxoSmithKline (GSK) are launching the Phase 3 randomised, observer blinded, placebo-controlled study. The study supported in the UK by the National Institute for Health Research (NIHR), NHS Research Scotland (NRS) and Health and Care Research Wales is the first to test a plant-derived COVID-19 vaccine candidate, and will evaluate the efficacy...

View Page

Key changes to UK amendment process

The devolved administrations, the HRA and the MHRA have agreed to make two key changes to the UK amendment process with effect from 25 March 2021 Firstly, the addition of a new NHS/HSC site or a change of PI at an NHS/HSC site for a CTIMP study will now be classified as a Non-Substantial Amendment*. This was previously considered a Substantial Amendment. The change is designed to speed up new site set up. This is possible because new sites were categorised as substantial due to EU gu...

View Page

Update on student research – new eligibility criteria from 1 September 2021

The HRA and the devolved administrations, supported by the Wessex Institute at the University of Southampton, have reviewed their approach to study approval for student research. The review aimed to ensure students have the best learning experience of health and social care research, and to reduce the time that the HRA, DAs and NHS Research Ethics Committees (RECs) spend advising on and reviewing student applications. In March 2020 student research approvals wer...

View Page

Saving and improving lives: the future of UK clinical research delivery

Today (Tuesday 23 March) a bold and ambitious vision for the future of clinical research delivery across the UK has been published. Scotland has worked alongside the UK nations to develop the vision, with input from NHS, regulators, medical research charities and life sciences industry. The vision sets out the ambition to create a patient-centred, pro-innovation and data-enabled clinical research environment, and empowers everyone across the health service to participa...

View Page

Huge ‘thank you’ to Scottish community as UK COVID-19 research passes one million participants

More than one million participants, including over 66,000 people in Scotland, are being thanked for their vital role in COVID-19 research across the UK. Coinciding with this remarkable milestone, the four UK nations are jointly launching the #ResearchVsCovid ‘thank you’ campaign to celebrate the efforts of participants, researchers and healthcare professionals for their involvement in COVID-19 research. Research has been a crucial part of the pandemi...

View Page